2199 participants
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-08-21
- Start Date:
- 2018-08-02
- Completion:
- 2023-08-14
Conditions
- Triple Negative Breast Cancer
Interventions
- DRUG